Latest News
|
More Articles...
- Tackling Health Disparities and Inequities for Women with Heart Failure: New Program Encourages Black and Latina Women to Demand More from Their Care
- US FDA Approves Jardiance® (Empagliflozin) to Treat Adults with Heart Failure Regardless of Left Ventricular Ejection Fraction
- Xcardia Announces First-In-Human Use of its New Xtractor Device for Cardiac Pacemaker and Defibrillator Lead Extraction Procedures
- Abbott Announces World’s First Implant of Dual-Chamber Leadless Pacemaker in Pivotal Trial
- Abbott Receives FDA Approval for Aveir™ VR Leadless Pacemaker System to Treat Patients with Slow Heart Rhythms
- Abbott Receives U.S. FDA Clearance for New Cardiac Mapping System to Improve How Doctors Treat Abnormal Heart Rhythms
- Abbott’s CardioMEMS™ HF System Receives FDA Approval to Support Patients Battling Earlier-stage Heart Failure
- Abbott Strengthens Left Atrial Appendage Closure Leadership with U.S. Availability of Amplatzer™ Steerable Delivery Sheath for the Company’s Amulet™ Device
- Adagio Medical Announces Successful First-In-Human Cases of Pulsed Field Cryoablation for Treatment of Atrial Fibrillation
- Atrial Fibrillation Clinical Trial with Novel Dual Activity Factor XI Agent Completes Enrollment
|
|
